<DOC>
	<DOCNO>NCT01678872</DOCNO>
	<brief_summary>The purpose study examine long term safety experimental gene transfer agent , RetinoStat® , design treat neovascular age-related macular degeneration .</brief_summary>
	<brief_title>A Follow-up Study Evaluate Safety RetinoStat® Patients With Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Must receive subretinal injection RetinoStat Must enrol Protocol RS1/001/10 Did receive RetinoStat® part RS1/001/10 protocol</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>